goat anti albumin Search Results


94
Fortis Life Sciences goat anti mouse albumin antibody
Urinalysis from untreated and 8K-NBD peptide-treated mdx mice at multiple time points. Urine samples (7.5 μL) were electrophoresed on a 10% resolving SDS-PAGE gel followed by visualization of separated proteins by Coomassie Blue R-250 staining. Representative urine samples collected after 1 wk of treatment (early urinalysis) and after 4 wks of treatment (final urinalysis) are shown in (A). Immunoblotting for <t>albumin</t> in <t>mouse</t> urine using an <t>anti-mouse</t> albumin antibody is shown in the far right lane of (A), confirming presence of the 68-kDa albumin protein in urine. Densitometric measurements of the 68-kDa albumin band present in all urine samples (see arrow in [A]) is shown in (B) as average band density ± standard error. In (B), an asterisk (*) indicates a significant difference between early urinalysis groups compared with untreated mdx (white bars); two asterisks (**) indicate a significant difference between late urinalysis groups compared with untreated mdx mice (black bars) and § indicates a significant difference between early and late treatment samples in specified treatment groups (p < 0.05). To represent relative amounts and timing of proteinuria in 8K-NBD peptide-treated mdx mice, the total number of protein bands after SDS-PAGE electrophoresis of urine samples from each mouse in the study was quantified and the data is presented as the average number of protein bands present in the gel ± standard error (C). In (C), an asterisk (*) indicates the 8K-NBD peptide treatment group is significantly different than untreated mdx (p < 0.05). In (D), 10 μL urine samples, collected from mdx mice prior to, and 30 min and 24 h after 1, 2 or 3 high-dose, d-8K-wild-type-NBD peptide injections were electrophoresed and stained as in (A) to show early onset of severe proteinuria in this treatment group. Age-matched mdx mice served as the untreated mdx group. n = number of animals per group.
Goat Anti Mouse Albumin Antibody, supplied by Fortis Life Sciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+albumin/Goat+Albumin+Antibody/pmc04559531-62-11-15
Average 94 stars, based on 1 article reviews
goat anti mouse albumin antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Bio-Rad goat anti human
Urinalysis from untreated and 8K-NBD peptide-treated mdx mice at multiple time points. Urine samples (7.5 μL) were electrophoresed on a 10% resolving SDS-PAGE gel followed by visualization of separated proteins by Coomassie Blue R-250 staining. Representative urine samples collected after 1 wk of treatment (early urinalysis) and after 4 wks of treatment (final urinalysis) are shown in (A). Immunoblotting for <t>albumin</t> in <t>mouse</t> urine using an <t>anti-mouse</t> albumin antibody is shown in the far right lane of (A), confirming presence of the 68-kDa albumin protein in urine. Densitometric measurements of the 68-kDa albumin band present in all urine samples (see arrow in [A]) is shown in (B) as average band density ± standard error. In (B), an asterisk (*) indicates a significant difference between early urinalysis groups compared with untreated mdx (white bars); two asterisks (**) indicate a significant difference between late urinalysis groups compared with untreated mdx mice (black bars) and § indicates a significant difference between early and late treatment samples in specified treatment groups (p < 0.05). To represent relative amounts and timing of proteinuria in 8K-NBD peptide-treated mdx mice, the total number of protein bands after SDS-PAGE electrophoresis of urine samples from each mouse in the study was quantified and the data is presented as the average number of protein bands present in the gel ± standard error (C). In (C), an asterisk (*) indicates the 8K-NBD peptide treatment group is significantly different than untreated mdx (p < 0.05). In (D), 10 μL urine samples, collected from mdx mice prior to, and 30 min and 24 h after 1, 2 or 3 high-dose, d-8K-wild-type-NBD peptide injections were electrophoresed and stained as in (A) to show early onset of severe proteinuria in this treatment group. Age-matched mdx mice served as the untreated mdx group. n = number of animals per group.
Goat Anti Human, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+albumin/Goat+anti+Human+Albumin/pmc00124615-151-70-72
Average 86 stars, based on 1 article reviews
goat anti human - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

92
Cusabio goat anti rabbit igg antibody
Urinalysis from untreated and 8K-NBD peptide-treated mdx mice at multiple time points. Urine samples (7.5 μL) were electrophoresed on a 10% resolving SDS-PAGE gel followed by visualization of separated proteins by Coomassie Blue R-250 staining. Representative urine samples collected after 1 wk of treatment (early urinalysis) and after 4 wks of treatment (final urinalysis) are shown in (A). Immunoblotting for <t>albumin</t> in <t>mouse</t> urine using an <t>anti-mouse</t> albumin antibody is shown in the far right lane of (A), confirming presence of the 68-kDa albumin protein in urine. Densitometric measurements of the 68-kDa albumin band present in all urine samples (see arrow in [A]) is shown in (B) as average band density ± standard error. In (B), an asterisk (*) indicates a significant difference between early urinalysis groups compared with untreated mdx (white bars); two asterisks (**) indicate a significant difference between late urinalysis groups compared with untreated mdx mice (black bars) and § indicates a significant difference between early and late treatment samples in specified treatment groups (p < 0.05). To represent relative amounts and timing of proteinuria in 8K-NBD peptide-treated mdx mice, the total number of protein bands after SDS-PAGE electrophoresis of urine samples from each mouse in the study was quantified and the data is presented as the average number of protein bands present in the gel ± standard error (C). In (C), an asterisk (*) indicates the 8K-NBD peptide treatment group is significantly different than untreated mdx (p < 0.05). In (D), 10 μL urine samples, collected from mdx mice prior to, and 30 min and 24 h after 1, 2 or 3 high-dose, d-8K-wild-type-NBD peptide injections were electrophoresed and stained as in (A) to show early onset of severe proteinuria in this treatment group. Age-matched mdx mice served as the untreated mdx group. n = number of animals per group.
Goat Anti Rabbit Igg Antibody, supplied by Cusabio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+albumin/Rabbit+anti-Goat+ALB+Polyclonal+Antibody/10__1155_slash_2020_slash_1365983-57-12-33
Average 92 stars, based on 1 article reviews
goat anti rabbit igg antibody - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
SouthernBiotech goat anti hsa
Urinalysis from untreated and 8K-NBD peptide-treated mdx mice at multiple time points. Urine samples (7.5 μL) were electrophoresed on a 10% resolving SDS-PAGE gel followed by visualization of separated proteins by Coomassie Blue R-250 staining. Representative urine samples collected after 1 wk of treatment (early urinalysis) and after 4 wks of treatment (final urinalysis) are shown in (A). Immunoblotting for <t>albumin</t> in <t>mouse</t> urine using an <t>anti-mouse</t> albumin antibody is shown in the far right lane of (A), confirming presence of the 68-kDa albumin protein in urine. Densitometric measurements of the 68-kDa albumin band present in all urine samples (see arrow in [A]) is shown in (B) as average band density ± standard error. In (B), an asterisk (*) indicates a significant difference between early urinalysis groups compared with untreated mdx (white bars); two asterisks (**) indicate a significant difference between late urinalysis groups compared with untreated mdx mice (black bars) and § indicates a significant difference between early and late treatment samples in specified treatment groups (p < 0.05). To represent relative amounts and timing of proteinuria in 8K-NBD peptide-treated mdx mice, the total number of protein bands after SDS-PAGE electrophoresis of urine samples from each mouse in the study was quantified and the data is presented as the average number of protein bands present in the gel ± standard error (C). In (C), an asterisk (*) indicates the 8K-NBD peptide treatment group is significantly different than untreated mdx (p < 0.05). In (D), 10 μL urine samples, collected from mdx mice prior to, and 30 min and 24 h after 1, 2 or 3 high-dose, d-8K-wild-type-NBD peptide injections were electrophoresed and stained as in (A) to show early onset of severe proteinuria in this treatment group. Age-matched mdx mice served as the untreated mdx group. n = number of animals per group.
Goat Anti Hsa, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+albumin/Goat+Anti-Human+Serum+Albumin%2C+Bovine+Serum+Albumin+ads-UNLB/med_rxiv__2025__11__18__25340499-354-6-8
Average 93 stars, based on 1 article reviews
goat anti hsa - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
SouthernBiotech polyclonal goat anti bovine anti human
Urinalysis from untreated and 8K-NBD peptide-treated mdx mice at multiple time points. Urine samples (7.5 μL) were electrophoresed on a 10% resolving SDS-PAGE gel followed by visualization of separated proteins by Coomassie Blue R-250 staining. Representative urine samples collected after 1 wk of treatment (early urinalysis) and after 4 wks of treatment (final urinalysis) are shown in (A). Immunoblotting for <t>albumin</t> in <t>mouse</t> urine using an <t>anti-mouse</t> albumin antibody is shown in the far right lane of (A), confirming presence of the 68-kDa albumin protein in urine. Densitometric measurements of the 68-kDa albumin band present in all urine samples (see arrow in [A]) is shown in (B) as average band density ± standard error. In (B), an asterisk (*) indicates a significant difference between early urinalysis groups compared with untreated mdx (white bars); two asterisks (**) indicate a significant difference between late urinalysis groups compared with untreated mdx mice (black bars) and § indicates a significant difference between early and late treatment samples in specified treatment groups (p < 0.05). To represent relative amounts and timing of proteinuria in 8K-NBD peptide-treated mdx mice, the total number of protein bands after SDS-PAGE electrophoresis of urine samples from each mouse in the study was quantified and the data is presented as the average number of protein bands present in the gel ± standard error (C). In (C), an asterisk (*) indicates the 8K-NBD peptide treatment group is significantly different than untreated mdx (p < 0.05). In (D), 10 μL urine samples, collected from mdx mice prior to, and 30 min and 24 h after 1, 2 or 3 high-dose, d-8K-wild-type-NBD peptide injections were electrophoresed and stained as in (A) to show early onset of severe proteinuria in this treatment group. Age-matched mdx mice served as the untreated mdx group. n = number of animals per group.
Polyclonal Goat Anti Bovine Anti Human, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+albumin/Goat+Anti-Bovine+Serum+Albumin%2C+Human+Serum+Albumin+ads-BIOT/10__1172_slash_jci119229-101-10-18
Average 92 stars, based on 1 article reviews
polyclonal goat anti bovine anti human - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

91
Valiant Co Ltd competitive elisa
Urinalysis from untreated and 8K-NBD peptide-treated mdx mice at multiple time points. Urine samples (7.5 μL) were electrophoresed on a 10% resolving SDS-PAGE gel followed by visualization of separated proteins by Coomassie Blue R-250 staining. Representative urine samples collected after 1 wk of treatment (early urinalysis) and after 4 wks of treatment (final urinalysis) are shown in (A). Immunoblotting for <t>albumin</t> in <t>mouse</t> urine using an <t>anti-mouse</t> albumin antibody is shown in the far right lane of (A), confirming presence of the 68-kDa albumin protein in urine. Densitometric measurements of the 68-kDa albumin band present in all urine samples (see arrow in [A]) is shown in (B) as average band density ± standard error. In (B), an asterisk (*) indicates a significant difference between early urinalysis groups compared with untreated mdx (white bars); two asterisks (**) indicate a significant difference between late urinalysis groups compared with untreated mdx mice (black bars) and § indicates a significant difference between early and late treatment samples in specified treatment groups (p < 0.05). To represent relative amounts and timing of proteinuria in 8K-NBD peptide-treated mdx mice, the total number of protein bands after SDS-PAGE electrophoresis of urine samples from each mouse in the study was quantified and the data is presented as the average number of protein bands present in the gel ± standard error (C). In (C), an asterisk (*) indicates the 8K-NBD peptide treatment group is significantly different than untreated mdx (p < 0.05). In (D), 10 μL urine samples, collected from mdx mice prior to, and 30 min and 24 h after 1, 2 or 3 high-dose, d-8K-wild-type-NBD peptide injections were electrophoresed and stained as in (A) to show early onset of severe proteinuria in this treatment group. Age-matched mdx mice served as the untreated mdx group. n = number of animals per group.
Competitive Elisa, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+albumin/HRP+IgG+Goat+Anti-Human+Albumin/pm40346200-348-10-13
Average 91 stars, based on 1 article reviews
competitive elisa - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

85
SouthernBiotech anti rnls polyclonal goat igg
Urinalysis from untreated and 8K-NBD peptide-treated mdx mice at multiple time points. Urine samples (7.5 μL) were electrophoresed on a 10% resolving SDS-PAGE gel followed by visualization of separated proteins by Coomassie Blue R-250 staining. Representative urine samples collected after 1 wk of treatment (early urinalysis) and after 4 wks of treatment (final urinalysis) are shown in (A). Immunoblotting for <t>albumin</t> in <t>mouse</t> urine using an <t>anti-mouse</t> albumin antibody is shown in the far right lane of (A), confirming presence of the 68-kDa albumin protein in urine. Densitometric measurements of the 68-kDa albumin band present in all urine samples (see arrow in [A]) is shown in (B) as average band density ± standard error. In (B), an asterisk (*) indicates a significant difference between early urinalysis groups compared with untreated mdx (white bars); two asterisks (**) indicate a significant difference between late urinalysis groups compared with untreated mdx mice (black bars) and § indicates a significant difference between early and late treatment samples in specified treatment groups (p < 0.05). To represent relative amounts and timing of proteinuria in 8K-NBD peptide-treated mdx mice, the total number of protein bands after SDS-PAGE electrophoresis of urine samples from each mouse in the study was quantified and the data is presented as the average number of protein bands present in the gel ± standard error (C). In (C), an asterisk (*) indicates the 8K-NBD peptide treatment group is significantly different than untreated mdx (p < 0.05). In (D), 10 μL urine samples, collected from mdx mice prior to, and 30 min and 24 h after 1, 2 or 3 high-dose, d-8K-wild-type-NBD peptide injections were electrophoresed and stained as in (A) to show early onset of severe proteinuria in this treatment group. Age-matched mdx mice served as the untreated mdx group. n = number of animals per group.
Anti Rnls Polyclonal Goat Igg, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+albumin/Goat+Anti-Human+Serum+Albumin%2C+Bovine+Serum+Albumin+ads-BIOT/pm35219026-126-0-26
Average 85 stars, based on 1 article reviews
anti rnls polyclonal goat igg - by Bioz Stars, 2026-11
85/100 stars
  Buy from Supplier

86
Thermo Fisher albumin polyclonal goat antibody novo biologicals nb60041532 ki
Urinalysis from untreated and 8K-NBD peptide-treated mdx mice at multiple time points. Urine samples (7.5 μL) were electrophoresed on a 10% resolving SDS-PAGE gel followed by visualization of separated proteins by Coomassie Blue R-250 staining. Representative urine samples collected after 1 wk of treatment (early urinalysis) and after 4 wks of treatment (final urinalysis) are shown in (A). Immunoblotting for <t>albumin</t> in <t>mouse</t> urine using an <t>anti-mouse</t> albumin antibody is shown in the far right lane of (A), confirming presence of the 68-kDa albumin protein in urine. Densitometric measurements of the 68-kDa albumin band present in all urine samples (see arrow in [A]) is shown in (B) as average band density ± standard error. In (B), an asterisk (*) indicates a significant difference between early urinalysis groups compared with untreated mdx (white bars); two asterisks (**) indicate a significant difference between late urinalysis groups compared with untreated mdx mice (black bars) and § indicates a significant difference between early and late treatment samples in specified treatment groups (p < 0.05). To represent relative amounts and timing of proteinuria in 8K-NBD peptide-treated mdx mice, the total number of protein bands after SDS-PAGE electrophoresis of urine samples from each mouse in the study was quantified and the data is presented as the average number of protein bands present in the gel ± standard error (C). In (C), an asterisk (*) indicates the 8K-NBD peptide treatment group is significantly different than untreated mdx (p < 0.05). In (D), 10 μL urine samples, collected from mdx mice prior to, and 30 min and 24 h after 1, 2 or 3 high-dose, d-8K-wild-type-NBD peptide injections were electrophoresed and stained as in (A) to show early onset of severe proteinuria in this treatment group. Age-matched mdx mice served as the untreated mdx group. n = number of animals per group.
Albumin Polyclonal Goat Antibody Novo Biologicals Nb60041532 Ki, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+albumin/albumin+polyclonal+goat+antibody+novo+biologicals+nb60041532+ki/pmc05100545__srep36586___s1-111-72-90
Average 86 stars, based on 1 article reviews
albumin polyclonal goat antibody novo biologicals nb60041532 ki - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

93
Valiant Co Ltd goat anti ova polyclonal antibodies
The <t>OVA</t> assay shows high sensitivity and specificity to detect intestinal barrier dysfunction in a mouse model of DSS-induced colitis. ( A ) OVA or FITC-D assay readouts from the plasma samples of nontreated (n = 8) or DSS-treated (n = 8) mice co-administered FITC-D (12 mg/mouse) and OVA (1 mg/mouse). Data presented are representative of at least 3 independent experiments. Statistical significance was determined by 1-way analysis of variance using the Tukey post hoc test. ( B ) Visualization of OVA localization in the distal colon of nontreated ( upper panel ) or DSS-treated for 6 days ( lower panel ) WT mice. Mice were orally gavaged with 1 mg/100 μL OVA and tissues were harvested 3 hours later for histology and stained with the same <t>rabbit</t> <t>anti-OVA</t> antibody used in the OVA assay. The localization of OVA (red) is highlighted with white arrowheads , along with stains for epithelium (E-cadherin, green), and nuclei (DAPI, blue). DAPI, 4′,6-diamidino-2-phenylindole. ∗ P ≤.05, ∗∗ P ≤.01, ∗∗∗ P ≤ .001, ∗∗∗∗ P ≤ .0001.
Goat Anti Ova Polyclonal Antibodies, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+albumin/IgG+Goat+Anti-Chicken+Albumin/pmc09791122-225-15-20
Average 93 stars, based on 1 article reviews
goat anti ova polyclonal antibodies - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Valiant Co Ltd goat anti rat
The <t>OVA</t> assay shows high sensitivity and specificity to detect intestinal barrier dysfunction in a mouse model of DSS-induced colitis. ( A ) OVA or FITC-D assay readouts from the plasma samples of nontreated (n = 8) or DSS-treated (n = 8) mice co-administered FITC-D (12 mg/mouse) and OVA (1 mg/mouse). Data presented are representative of at least 3 independent experiments. Statistical significance was determined by 1-way analysis of variance using the Tukey post hoc test. ( B ) Visualization of OVA localization in the distal colon of nontreated ( upper panel ) or DSS-treated for 6 days ( lower panel ) WT mice. Mice were orally gavaged with 1 mg/100 μL OVA and tissues were harvested 3 hours later for histology and stained with the same <t>rabbit</t> <t>anti-OVA</t> antibody used in the OVA assay. The localization of OVA (red) is highlighted with white arrowheads , along with stains for epithelium (E-cadherin, green), and nuclei (DAPI, blue). DAPI, 4′,6-diamidino-2-phenylindole. ∗ P ≤.05, ∗∗ P ≤.01, ∗∗∗ P ≤ .001, ∗∗∗∗ P ≤ .0001.
Goat Anti Rat, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+albumin/Anti-rat+albumin+goat+antiserum/bio_rxiv__2025__10__08__681084-282-17-19
Average 93 stars, based on 1 article reviews
goat anti rat - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Nof corporation pegylated anti-human albumin goat serum γ fraction a reagent
The <t>OVA</t> assay shows high sensitivity and specificity to detect intestinal barrier dysfunction in a mouse model of DSS-induced colitis. ( A ) OVA or FITC-D assay readouts from the plasma samples of nontreated (n = 8) or DSS-treated (n = 8) mice co-administered FITC-D (12 mg/mouse) and OVA (1 mg/mouse). Data presented are representative of at least 3 independent experiments. Statistical significance was determined by 1-way analysis of variance using the Tukey post hoc test. ( B ) Visualization of OVA localization in the distal colon of nontreated ( upper panel ) or DSS-treated for 6 days ( lower panel ) WT mice. Mice were orally gavaged with 1 mg/100 μL OVA and tissues were harvested 3 hours later for histology and stained with the same <t>rabbit</t> <t>anti-OVA</t> antibody used in the OVA assay. The localization of OVA (red) is highlighted with white arrowheads , along with stains for epithelium (E-cadherin, green), and nuclei (DAPI, blue). DAPI, 4′,6-diamidino-2-phenylindole. ∗ P ≤.05, ∗∗ P ≤.01, ∗∗∗ P ≤ .001, ∗∗∗∗ P ≤ .0001.
Pegylated Anti Human Albumin Goat Serum γ Fraction A Reagent, supplied by Nof corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+albumin/pegylated+anti+human+albumin+goat+serum+%CE%B3+fraction+a+reagent/us07981690-75-3-14
Average 90 stars, based on 1 article reviews
pegylated anti-human albumin goat serum γ fraction a reagent - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Cappel Laboratories goat anti-pig albumin antibody
The <t>OVA</t> assay shows high sensitivity and specificity to detect intestinal barrier dysfunction in a mouse model of DSS-induced colitis. ( A ) OVA or FITC-D assay readouts from the plasma samples of nontreated (n = 8) or DSS-treated (n = 8) mice co-administered FITC-D (12 mg/mouse) and OVA (1 mg/mouse). Data presented are representative of at least 3 independent experiments. Statistical significance was determined by 1-way analysis of variance using the Tukey post hoc test. ( B ) Visualization of OVA localization in the distal colon of nontreated ( upper panel ) or DSS-treated for 6 days ( lower panel ) WT mice. Mice were orally gavaged with 1 mg/100 μL OVA and tissues were harvested 3 hours later for histology and stained with the same <t>rabbit</t> <t>anti-OVA</t> antibody used in the OVA assay. The localization of OVA (red) is highlighted with white arrowheads , along with stains for epithelium (E-cadherin, green), and nuclei (DAPI, blue). DAPI, 4′,6-diamidino-2-phenylindole. ∗ P ≤.05, ∗∗ P ≤.01, ∗∗∗ P ≤ .001, ∗∗∗∗ P ≤ .0001.
Goat Anti Pig Albumin Antibody, supplied by Cappel Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+albumin/goat+anti+pig+albumin+antibody/pm16035089-50-13-17
Average 90 stars, based on 1 article reviews
goat anti-pig albumin antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Urinalysis from untreated and 8K-NBD peptide-treated mdx mice at multiple time points. Urine samples (7.5 μL) were electrophoresed on a 10% resolving SDS-PAGE gel followed by visualization of separated proteins by Coomassie Blue R-250 staining. Representative urine samples collected after 1 wk of treatment (early urinalysis) and after 4 wks of treatment (final urinalysis) are shown in (A). Immunoblotting for albumin in mouse urine using an anti-mouse albumin antibody is shown in the far right lane of (A), confirming presence of the 68-kDa albumin protein in urine. Densitometric measurements of the 68-kDa albumin band present in all urine samples (see arrow in [A]) is shown in (B) as average band density ± standard error. In (B), an asterisk (*) indicates a significant difference between early urinalysis groups compared with untreated mdx (white bars); two asterisks (**) indicate a significant difference between late urinalysis groups compared with untreated mdx mice (black bars) and § indicates a significant difference between early and late treatment samples in specified treatment groups (p < 0.05). To represent relative amounts and timing of proteinuria in 8K-NBD peptide-treated mdx mice, the total number of protein bands after SDS-PAGE electrophoresis of urine samples from each mouse in the study was quantified and the data is presented as the average number of protein bands present in the gel ± standard error (C). In (C), an asterisk (*) indicates the 8K-NBD peptide treatment group is significantly different than untreated mdx (p < 0.05). In (D), 10 μL urine samples, collected from mdx mice prior to, and 30 min and 24 h after 1, 2 or 3 high-dose, d-8K-wild-type-NBD peptide injections were electrophoresed and stained as in (A) to show early onset of severe proteinuria in this treatment group. Age-matched mdx mice served as the untreated mdx group. n = number of animals per group.

Journal: Molecular Medicine

Article Title: d -Amino Acid Substitution of Peptide-Mediated NF-κB Suppression in mdx Mice Preserves Therapeutic Benefit in Skeletal Muscle, but Causes Kidney Toxicity

doi: 10.2119/molmed.2013.00141

Figure Lengend Snippet: Urinalysis from untreated and 8K-NBD peptide-treated mdx mice at multiple time points. Urine samples (7.5 μL) were electrophoresed on a 10% resolving SDS-PAGE gel followed by visualization of separated proteins by Coomassie Blue R-250 staining. Representative urine samples collected after 1 wk of treatment (early urinalysis) and after 4 wks of treatment (final urinalysis) are shown in (A). Immunoblotting for albumin in mouse urine using an anti-mouse albumin antibody is shown in the far right lane of (A), confirming presence of the 68-kDa albumin protein in urine. Densitometric measurements of the 68-kDa albumin band present in all urine samples (see arrow in [A]) is shown in (B) as average band density ± standard error. In (B), an asterisk (*) indicates a significant difference between early urinalysis groups compared with untreated mdx (white bars); two asterisks (**) indicate a significant difference between late urinalysis groups compared with untreated mdx mice (black bars) and § indicates a significant difference between early and late treatment samples in specified treatment groups (p < 0.05). To represent relative amounts and timing of proteinuria in 8K-NBD peptide-treated mdx mice, the total number of protein bands after SDS-PAGE electrophoresis of urine samples from each mouse in the study was quantified and the data is presented as the average number of protein bands present in the gel ± standard error (C). In (C), an asterisk (*) indicates the 8K-NBD peptide treatment group is significantly different than untreated mdx (p < 0.05). In (D), 10 μL urine samples, collected from mdx mice prior to, and 30 min and 24 h after 1, 2 or 3 high-dose, d-8K-wild-type-NBD peptide injections were electrophoresed and stained as in (A) to show early onset of severe proteinuria in this treatment group. Age-matched mdx mice served as the untreated mdx group. n = number of animals per group.

Article Snippet: The albumin band was confirmed by immunoblotting with a 1:1000 diluted goat anti-mouse albumin antibody (Bethyl Laboratories Inc.), followed by a 1:30,000 diluted IRDye 800CW goat anti-mouse IgG (H + L) conjugated secondary antibody (LI-COR Biosciences).

Techniques: SDS Page, Staining, Western Blot, Electrophoresis

The OVA assay shows high sensitivity and specificity to detect intestinal barrier dysfunction in a mouse model of DSS-induced colitis. ( A ) OVA or FITC-D assay readouts from the plasma samples of nontreated (n = 8) or DSS-treated (n = 8) mice co-administered FITC-D (12 mg/mouse) and OVA (1 mg/mouse). Data presented are representative of at least 3 independent experiments. Statistical significance was determined by 1-way analysis of variance using the Tukey post hoc test. ( B ) Visualization of OVA localization in the distal colon of nontreated ( upper panel ) or DSS-treated for 6 days ( lower panel ) WT mice. Mice were orally gavaged with 1 mg/100 μL OVA and tissues were harvested 3 hours later for histology and stained with the same rabbit anti-OVA antibody used in the OVA assay. The localization of OVA (red) is highlighted with white arrowheads , along with stains for epithelium (E-cadherin, green), and nuclei (DAPI, blue). DAPI, 4′,6-diamidino-2-phenylindole. ∗ P ≤.05, ∗∗ P ≤.01, ∗∗∗ P ≤ .001, ∗∗∗∗ P ≤ .0001.

Journal: Cellular and Molecular Gastroenterology and Hepatology

Article Title: Highly Sensitive, Flow Cytometry-Based Measurement of Intestinal Permeability in Models of Experimental Colitis

doi: 10.1016/j.jcmgh.2022.10.004

Figure Lengend Snippet: The OVA assay shows high sensitivity and specificity to detect intestinal barrier dysfunction in a mouse model of DSS-induced colitis. ( A ) OVA or FITC-D assay readouts from the plasma samples of nontreated (n = 8) or DSS-treated (n = 8) mice co-administered FITC-D (12 mg/mouse) and OVA (1 mg/mouse). Data presented are representative of at least 3 independent experiments. Statistical significance was determined by 1-way analysis of variance using the Tukey post hoc test. ( B ) Visualization of OVA localization in the distal colon of nontreated ( upper panel ) or DSS-treated for 6 days ( lower panel ) WT mice. Mice were orally gavaged with 1 mg/100 μL OVA and tissues were harvested 3 hours later for histology and stained with the same rabbit anti-OVA antibody used in the OVA assay. The localization of OVA (red) is highlighted with white arrowheads , along with stains for epithelium (E-cadherin, green), and nuclei (DAPI, blue). DAPI, 4′,6-diamidino-2-phenylindole. ∗ P ≤.05, ∗∗ P ≤.01, ∗∗∗ P ≤ .001, ∗∗∗∗ P ≤ .0001.

Article Snippet: To conjugate the antibody to the beads, activated CML beads were resuspended in 100 μL goat anti-OVA polyclonal antibodies (#0855303; MP Biomedicals) and incubated on a shaker set at 800 RPM for 4 hours at room temperature.

Techniques: Staining